A drug that fights the spread of HIV is being handed out to low-income youth in the East Bay, according to reports.
A new program is making doses of Truvada — a drug made by Foster City-based company Gilead which can cut down on the risk of transmitting the disease from 42 to 75 percent — available to about 100 low-income youth, the Bay Area News Group reported.
Chris Roberts
NBC Bay Area | Copyright NBC Owned Television Stations
Read More
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
